CARLSBAD, Calif., June 3, 2011 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) has been honored by IDG's CIO magazine as a part of the 2011 CIO 100, an annual award program that recognizes organizations around the world that exemplify the highest level of operational and strategic excellence in information technology (IT).
As an innovative life science company, Life Technologies has been a pioneer in the use of mobile computing platforms for business intelligence and has been recognized globally in the Wall Street Journal, the New York Times and ComputerWorld for its mobility applications, including Roambi software by MeLLmo LLC. Life Technologies has implemented a broad-reaching program for improving employee
collaboration, communications and productivity through internal social networking applications that improve communications among more than 160 locations around the world. In addition, the company has installed video conferencing (tele-presence) suites at 30 global sites, saving more than a million dollars a year in travel expenses.
CIO magazine identifies and honors 100 organizations that have distinguished themselves by creating business value through the effective and innovative use of IT. Other honorees include Advanced Micro Devices, the GAP, Bayer HealthCare Pharmaceuticals USA and NBC News.
"This recognition showcases how finding a better way to serve information throughout the organization can lead to improvements in our business," said Joseph Beery, Chief Information Officer for Life Technologies. "We continue to demonstrate how being innovative in our use of information technologies can help contribute to an organization's communications and bottom line."
About Life Technologies
Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific and medical advancements that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance the fields of discovery and translational research, molecular medicine, stem cell-based therapies, food safety and animal health, and 21st century forensics. The company manufactures both molecular diagnostic and research use only products. Life Technologies' industry-leading brands are found in nearly every life sciences lab in the world and include innovative instrument systems under the Applied Biosystems and Ion Torrent
names, as well as, the broadest range of reagents with its Invitrogen, Gibco, Ambion, Molecular Probes and Taqman products. Life Technologies had sales of $3.6 billion in 2010, has a workforce of approximately 11,000 people, has a presence in approximately 160 countries, and possesses one of the largest intellectual property estates in the life sciences industry, with approximately 3,900 patents and exclusive licenses. For more information on how we are making a difference, please visit our website: http://www.lifetechnologies.com. Follow Life Technologies on Twitter @lifetech and on Facebook.
Life Technologies' Safe Harbor Statement
This press release includes forward-looking statements about Life Technologies' anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and Life Technologies' plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Any statements that are not statements of historical fact are forward-looking statements. When used, the words "believe," "plan," "intend," "anticipate," "target," "estimate," "expect" and the like, and/or future tense or conditional
constructions ("will," "may," "could," "should," etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by Life Technologies with the Securities and Exchange Commission. Life Technologies undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.
Life Technologies Contact
SOURCE Life Technologies Corporation